Book a demo

Company intelligence

Evommune

Developing innovative therapies that target key drivers of chronic inflammatory diseases.

Biotechnology Research
Palo Alto, US
69 employees
Founded 2020
1 public signals

About Evommune

Chronic inflammation is a significant healthcare problem in the world, substantially impacting patients’ quality of life and leading to life-threatening conditions. Our mission is to improve patients’ daily lives and prevent the long-term effects of uncontrolled inflammation that are a consequence of the limitations of existing therapies. We are discovering and developing innovative therapies that target key drivers of chronic inflammatory diseases.

Verified activity

Signals from Evommune

1 published signal

Find the companies already in motion.

Customize signals around your market, buyers, competitors, and investment thesis.

© 2026 SeedOpsCompany intelligence.

SeedOps.